• 不 限
  • 期刊论文
  • 硕博论文
  • 会议论文
  • 报 纸
  • 英文论文
  2. 您的位置
  3. 首页
  4. 会议论文
  5. A Cross-Sectional Study on Intrahepatic Cholestasis Indicators of Viral Hepatitis Patients

A Cross-Sectional Study on Intrahepatic Cholestasis Indicators of Viral Hepatitis Patients

来源 :2014年APASL专题会议暨第四届乙型病毒性肝炎专题会议 | 被引量 : 0次 | 上传用户：studyrec
【摘 要】
：
Background:AIM:Intrahepatic cholestasis(IHC) is common in viral hepatitis patients.Although the patients are clinically asymptomatic,the IHC indicators,alkaline phosphatase(ALP) or gamma glutamyltrans
【作 者】
：
Jun Cheng Wenhong Zhang Yang Cao Xingxiang Yang Jiangbin Wang 
【机 构】
：
Beijing Ditan Hospital Capital Medical University,Bejing
【出 处】
：
2014年APASL专题会议暨第四届乙型病毒性肝炎专题会议
【发表日期】
：
2014年4期
下载到本地 , 更方便阅读
下载此文 赞助VIP
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Background:AIM:Intrahepatic cholestasis(IHC) is common in viral hepatitis patients.Although the patients are clinically asymptomatic,the IHC indicators,alkaline phosphatase(ALP) or gamma glutamyltransferase(GGT),remain abnormal.This study is to investigate the IHC indicators for in-patients with viral hepatitis when they are being discharged,and to explore the correlation between IHC indicators and liver fibrosis.
其他文献
Fine mapping analysis of HLA-DP/DQ gene clusters reveals the key role of HLA-DPB1 UTR3 region on sus
Background:Genetic studies have been conducted to investigate host susceptibility of the hepatitis B virus(HBV) infection;SNPs in the HLA region(6p21) were mostly reported associated with the disease
会议
Assessment of currently accepted criteria for virologic breakthrough in chronic hepatitis B patients
Background:We investigated whether the concept of virologic breakthrough suggested by current guidelines or literatures is appropriate for treatment with entecavir(ETV) in the era of sensitive HBV DNA
会议
Comparison of the efficacy of tenofovir and entecavir for the treatment of nucleos(t)ide-naive patie
Background:An important goal in the treatment of chronic hepatitis B virus(HBV) infection is to prevent hepatocellular carcinoma and liver cirrhosis by suppressing HBV replication.
会议
Durability of HBeAg Seroconversion of Telbivudine as Monotherapy and as Combination Therapy with Ade
Background:The EFFORT study have concluded that adjusting treatment strategy is recommended for suboptimal virological responders to telbivudine(LdT) at week 24,adding on adefovir(ADV) can benefit the
会议
Combination treatment of Polyethylene Glycol Thymosin alpha1 and Adefovir for BeAg-positive Chronic
Background:This trial is to assess the efficacy and safety of Polyethylene Glycol thymosin alpha1(PEG-Tα1),a new long immunomodulator(Category 1.1 of Chemical Drugs) being developed from Hansoh Pharma
会议
Sequential PEG-IFN therapy in HBeAg positive chronic hepatitis B patients treated with nucleos(t)ide
Background:To investigate the course and efficacy of sequential PEG-IFN treatment for poor effect of HBeAg positive chronic hepatitis B patients treated with nucleos(t)ide analogue.
会议
Research the relationship between liver pathology and clinical at early cirrhosis patients infected
Background:Discuss differences between early cirrhosis and no cirrhosis patients in chronic hepatitis B(CHB)patients at HBV genotypes and nontraumatic indexs commonly used in clinical.
会议
Effect of Nucleos(t)ide analogue combined with traditional Chinese medicine on liver fibrosis in chr
BACKGROUND & AIMS:Traditional Chinese medicine(TCM),Biejiaruangan Compound(BJRGC),containing Carapax trionycis,Cordyceps sinensis and other 9 herbs has been used to treat liver fibrosis for almost two
会议
STUDY OF RELATIONSHIP BETWEEN HBV BCP/PC REGION QUASISPECIES WITH RELAPSE IN CHB PATIENTS WITH LAMIV
Background:To investigate the relationship between HBV DNA BCP/PC region quasispecies features with relapse until meeting endpoint criteria in CHB patients with LAM treatment Methods:43 CHB patients l
会议
The influence of combined antiretrovirus therapy on liver diseases among HIV/HBV/HCV triple infectio
Background:To investigate the influence of combined antiretrovirus therapy on replication of HBV or HCV and the occurrence of end-stage-liver diseases among HIV/HBV/HCV triple infection patients.
会议